My view on DivislabDivislab
Forming inverse Head&Shoulder
Looking tgt 3850-3860-3880++
in very short term👆
Keeping on radar Divislab 3900 CE may contract
52.10INR
18.23 BINR
77.49 BINR
127.61 M
About DIVIS LABORATORIES LTD.
Sector
CEO
Satchandra Kiran Divi
Headquarters
Hyderabad
Website
Employees (FY)
16.91 K
Founded
1990
ISIN
INE361B01024
FIGI
BBG000DJVXR7
Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients. It also provides manufacturing of generic APIs, nutraceutical ingredients, and custom synthesis for big pharma. The company was founded by Murali Krishna Prasad Divi on October 12, 1990 and is headquartered in Hyderabad, India.
Divis Lab! ready to reverse ??- Gap Filling Done
- Trendline tested 4 times i.e. weakening
- Two Dojis at the gap zone indicating indecision
- A good bullish sign here can mean a potential up move
- Given that the pharma sector hasn't performed in the last year, we may see some momentum in the coming period.
DISCLAIMER: We a
devis lab--buy on dipcurrently in 1st wave of 3rd wave and is likely to achieve very high targets of 5600( previous high) and above . Stock turned negative on head and shoulder formation and achieved lower trg of 3350 and end of 2nd wave now 1st impulsive going on once correction sets in buy the stock and accumulate.
My view on DivislabDivislab
Trendline breakout possible
Above 3530
Looking target 3600-3640++
Very short term
Keeping on radar Divislab 3500 CE
Divis labDivis lab long term view
Divi's Lab appears to be coiling up! The chart suggests a consolidation phase, where the price is trading within a range. This could be a sign of potential breakout. If the stock breaks above its previous all-time high (ATH), it could trigger a price discovery cycle, where t
Head & Shoulder breakdown in DIVIS Labs.Divis Lab has broken down from Head & Shoulder pattern and has also retested the support trendline from which it broke down last week.
Entry, Stoploss & Targets are marked on chart.
Divislab trade opportunity Stoploss 3440(1hr candle close below 3440)
Short term long
(sideways upside) target1&2 3540,3560
Investment Opportunity Analysis: DIVISLAB
Introduction:
DIVIS LAB, a prominent player in the pharmaceutical sector, has recently experienced a correction of 15% from its recent peak. This correction aligns with the formation of an ABC pattern within the Elliott Wave structure, indicating potential buying opportunities. Furthermore, the st
devis lab--buyonce crosses 3565 , 10 days moving average will show bounce from neckline and will be bullish once crosses 20 days moving average3634 will be bullish for stock. buy with a small stop loss and trail it . 200 DMA 3653 for more strenght and trend to become bullish .MACD hourly showing bottoming out .
My view on DIVISLABDivislab
Forming Head & Shoulder pattern
Looking weak for tgt 3400-3380-3360++
Keeping on radar Divislab 3500 PE (march)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DIVISLAB is 3816.45 INR — it has increased by 1.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange DIVIS LABORATORIES LTD. stocks are traded under the ticker DIVISLAB.
DIVIS LABORATORIES LTD. is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
DIVISLAB stock is 1.48% volatile and has beta coefficient of 1.26. Check out the list of the most volatile stocks — is DIVIS LABORATORIES LTD. there?
DIVISLAB earnings for the last quarter are 13.10 INR per share, whereas the estimation was 16.02 INR resulting in a −18.21% surprise. The estimated earnings for the next quarter are 15.50 INR per share. See more details about DIVIS LABORATORIES LTD. earnings.
DIVIS LABORATORIES LTD. revenue for the last quarter amounts to 19.09 B INR despite the estimated figure of 19.20 B INR. In the next quarter revenue is expected to reach 19.92 B INR.
Yes, you can track DIVIS LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
DIVISLAB stock has risen by 3.39% compared to the previous week, the month change is a 11.74% rise, over the last year DIVIS LABORATORIES LTD. has showed a 19.15% increase.
DIVISLAB net income for the last quarter is 3.58 B INR, while the quarter before that showed 3.48 B INR of net income which accounts for 2.87% change. Track more DIVIS LABORATORIES LTD. financial stats to get the full picture.
Today DIVIS LABORATORIES LTD. has the market capitalization of 1.00 T, it has decreased by 0.76% over the last week.
Yes, DIVISLAB dividends are paid annually. The last dividend per share was 30.00 INR. As of today, Dividend Yield (TTM)% is 0.80%. Tracking DIVIS LABORATORIES LTD. dividends might help you take more informed decisions.
DIVIS LABORATORIES LTD. dividend yield was 1.06% in 2022, and payout ratio reached 43.68%. The year before the numbers were 0.68% and 26.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DIVISLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIVIS LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 16.91 K employees. See our rating of the largest employees — is DIVIS LABORATORIES LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIVIS LABORATORIES LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIVIS LABORATORIES LTD. stock shows the strong buy signal. See more of DIVIS LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DIVIS LABORATORIES LTD. future price: according to them, DIVISLAB price has a max estimate of 4372.00 INR and a min estimate of 2541.00 INR. Read a more detailed DIVIS LABORATORIES LTD. forecast: see what analysts think of DIVIS LABORATORIES LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIVIS LABORATORIES LTD. EBITDA is 19.64 B INR, and current EBITDA margin is 31.04%. See more stats in DIVIS LABORATORIES LTD. financial statements.